The association between urine neutrophil gelatinase-associated lipocalin and UTI in people with neurogenic lower urinary tract dysfunction
Study design Secondary analysis of urine samples collected from a prospective within-subject clinical trial. Objectives Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine i...
Saved in:
Published in | Spinal cord Vol. 59; no. 9; pp. 959 - 966 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.09.2021
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1362-4393 1476-5624 1476-5624 |
DOI | 10.1038/s41393-020-00552-x |
Cover
Loading…
Abstract | Study design
Secondary analysis of urine samples collected from a prospective within-subject clinical trial.
Objectives
Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.
Setting
Greater Washington D.C. region.
Methods
Urine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of “Not UTI”, “Unlikely UTI”, and “Likely UTI” based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal–Wallis and post hoc Dunn’s test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.
Results
Twenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (
n
= 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (
n
= 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (
n
= 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (
p
< 0.05) and No UTI (
p
< 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00–1.02),
p
= 0.049).
Conclusions
Adults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.
Sponsorship
Patient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind. |
---|---|
AbstractList | Study design
Secondary analysis of urine samples collected from a prospective within-subject clinical trial.
Objectives
Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.
Setting
Greater Washington D.C. region.
Methods
Urine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of “Not UTI”, “Unlikely UTI”, and “Likely UTI” based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal–Wallis and post hoc Dunn’s test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.
Results
Twenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (
n
= 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (
n
= 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (
n
= 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (
p
< 0.05) and No UTI (
p
< 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00–1.02),
p
= 0.049).
Conclusions
Adults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.
Sponsorship
Patient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind. Study designSecondary analysis of urine samples collected from a prospective within-subject clinical trial.ObjectivesDescribe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.SettingGreater Washington D.C. region.MethodsUrine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of “Not UTI”, “Unlikely UTI”, and “Likely UTI” based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal–Wallis and post hoc Dunn’s test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.ResultsTwenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (n = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (n = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (n = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (p < 0.05) and No UTI (p < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00–1.02), p = 0.049).ConclusionsAdults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.SponsorshipPatient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind. Secondary analysis of urine samples collected from a prospective within-subject clinical trial.STUDY DESIGNSecondary analysis of urine samples collected from a prospective within-subject clinical trial.Describe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.OBJECTIVESDescribe the baseline variation in urine neutrophil gelatinase-associated lipocalin (uNGAL) levels in adults with neurogenic lower urinary tract dysfunction (NLUTD) and determine if uNGAL levels vary according to likelihood of having a UTI.Greater Washington D.C. region.SETTINGGreater Washington D.C. region.Urine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of "Not UTI", "Unlikely UTI", and "Likely UTI" based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal-Wallis and post hoc Dunn's test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.METHODSUrine samples were collected from a cohort of adults with NLUTD from a clinical trial. Samples were divided into groups of "Not UTI", "Unlikely UTI", and "Likely UTI" based on symptoms and urine culture results. uNGAL was compared between groups using Kruskal-Wallis and post hoc Dunn's test. Mixed effects logistic model was used to assess the association of uNGAL and Likely UTI.Twenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (n = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (n = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (n = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (p < 0.05) and No UTI (p < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00-1.02), p = 0.049).RESULTSTwenty-seven participants provided a total of 104 samples. uNGAL levels were lowest for the No UTI group (n = 29; 37 ng/ml interquartile range (IQR) (15, 71)), intermediate for the Unlikely UTI group (n = 67; 95 ng/ml IQR (37, 161)) and highest for the Likely UTI group (n = 8; 187 ng/ml IQR(146, 224)). uNGAL levels were higher in those with Likely UTI compared to both Unlikely UTI (p < 0.05) and No UTI (p < 0.01). uNGAL had an association with Likely UTI (OR 1.01, 95% CI (1.00-1.02), p = 0.049).Adults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.CONCLUSIONSAdults with NLUTD have notable variation in uNGAL levels in the absence of symptoms potentially due to UTI. uNGAL levels are higher in those who are likely to have UTI have higher uNGAL levels compared to those with non-specific symptoms and/or less growth on urine culture. uNGAL may have utility as a marker of UTI in people with NLUTD.Patient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind.SPONSORSHIPPatient-Centered Outcomes Research Institute (PCORI) funded this work. Bioporto provided partial salary support for SLG, IL, and OKL. NGAL ELISAs were provided by Bioporto in kind. |
Author | Lamanna, Olivia K. Ljungberg, Inger Forster, Catherine S. Sprague, Bruce M. Rounds, Amanda Groah, Suzanne L. |
AuthorAffiliation | 5. MedStar Georgetown University Hospital, Washington, DC, 20057 1. Biomedical Research Institute, Rockville, MD 20850 3. MedStar National Rehabilitation Hospital, Washington, D.C, 20010 2. Children’s National Hospital, Washington, D.C., 20010 4. MedStar Health Research Institute, Hyattsville, MD 20783 |
AuthorAffiliation_xml | – name: 4. MedStar Health Research Institute, Hyattsville, MD 20783 – name: 1. Biomedical Research Institute, Rockville, MD 20850 – name: 5. MedStar Georgetown University Hospital, Washington, DC, 20057 – name: 2. Children’s National Hospital, Washington, D.C., 20010 – name: 3. MedStar National Rehabilitation Hospital, Washington, D.C, 20010 |
Author_xml | – sequence: 1 givenname: Catherine S. orcidid: 0000-0002-6233-1070 surname: Forster fullname: Forster, Catherine S. email: forstercs@upmc.edu organization: Biomedical Research Institute, Children’s National Hospital, UPMC Children’s Hospital of Pittsburgh – sequence: 2 givenname: Olivia K. surname: Lamanna fullname: Lamanna, Olivia K. organization: Biomedical Research Institute, Children’s National Hospital – sequence: 3 givenname: Amanda surname: Rounds fullname: Rounds, Amanda organization: MedStar National Rehabilitation Hospital, MedStar Health Research Institute – sequence: 4 givenname: Bruce M. surname: Sprague fullname: Sprague, Bruce M. organization: Children’s National Hospital – sequence: 5 givenname: Inger surname: Ljungberg fullname: Ljungberg, Inger organization: MedStar National Rehabilitation Hospital, MedStar Health Research Institute – sequence: 6 givenname: Suzanne L. orcidid: 0000-0003-1213-1959 surname: Groah fullname: Groah, Suzanne L. organization: MedStar National Rehabilitation Hospital, MedStar Georgetown University Hospital |
BookMark | eNp9kUtv1DAUhS1URB_wB1hZYsMmxY_YSVYIVTwqVWIzrC3Hvp5x5bGDnTDtX-BX45lpQXTRla90v3Pusc45OokpAkJvKbmkhPcfSkv5wBvCSEOIEKy5e4HOaNvJRkjWntSZS9a0lTlF56XcEkIGOvSv0Clng-R1eYZ-rzaAdSnJeD37FPEI8w4g4iX7CDjCMuc0bXzAawiViLpA88iDxcFPyejgI9bR4h-ra1zHCdIUAO_8vNk75LSG6A0OaQf5YKzzPZ6zNjO298Ut0exPv0YvnQ4F3jy8F2j15fPq6ltz8_3r9dWnm8a0gs0No86Cpr3hjko2DtY5041Ae6altdKKru-15lSLHoCDBTOOmlpr3OiE1fwCfTzaTsu4BWsg1iRBTdlvayyVtFf_b6LfqHX6pSjtCGMdqQ7vHxxy-rlAmdXWFwMh6AhpKYq1rWiZrB1U9N0T9DYtOdbvKSakYF3HO1YpdqRMTqVkcH_TUKL2Vatj1apWrQ5Vq7sq6p-IjJ8PHdbUPjwv5UdpqXfiGvK_VM-o_gDEPMWk |
CitedBy_id | crossref_primary_10_1007_s00467_024_06321_9 crossref_primary_10_1038_s41393_021_00683_9 crossref_primary_10_3389_fped_2024_1368583 crossref_primary_10_3390_diagnostics13030468 crossref_primary_10_1177_11772719221144459 |
Cites_doi | 10.1016/j.clinbiochem.2015.08.003 10.1002/jcla.21962 10.1038/ki.2012.195 10.1007/s00467-009-1279-6 10.1186/1479-5876-10-174 10.1016/j.jbi.2008.08.010 10.1681/ASN.2006080882 10.1016/j.juro.2016.01.088 10.1007/s00467-011-1856-3 10.1016/j.ajic.2014.02.003 10.1016/j.apmr.2017.10.005 10.1016/j.jpurol.2018.12.008 10.7326/0003-4819-148-11-200806030-00003 10.1128/JCM.05852-11 10.1007/s00467-014-2905-5 10.2340/16501977-1207 10.1007/s00467-018-3936-0 10.1371/journal.pone.0171114 10.1172/JCI71630 10.1016/j.juro.2013.12.013 10.1310/sci2503-214 10.1016/S0003-9993(95)80615-6 10.1038/sc.2013.77 10.1086/650482 10.1371/journal.pone.0197568 10.1681/ASN.2009010065 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to International Spinal Cord Society 2020 The Author(s), under exclusive licence to International Spinal Cord Society 2020. 2020. The Author(s), under exclusive licence to International Spinal Cord Society. |
Copyright_xml | – notice: The Author(s), under exclusive licence to International Spinal Cord Society 2020 – notice: The Author(s), under exclusive licence to International Spinal Cord Society 2020. – notice: 2020. The Author(s), under exclusive licence to International Spinal Cord Society. |
DBID | AAYXX CITATION 3V. 7QL 7RV 7T7 7TK 7U9 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7N M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/s41393-020-00552-x |
DatabaseName | CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central - New (Subscription) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-5624 |
EndPage | 966 |
ExternalDocumentID | PMC11702270 10_1038_s41393_020_00552_x |
GrantInformation_xml | – fundername: Patient-Centered Outcomes Research Institute (PCORI) grantid: AD-1310-08215; AD-1310-08215; AD-1310-08215 funderid: https://doi.org/10.13039/100006093 – fundername: OL received partial salary support from Bioporto. NGAL ELISAS were provided in kind by Bioport – fundername: IL received partial salary support from Bioporto |
GroupedDBID | --- -Q- .GJ 0R~ 123 2QV 2WC 36B 39C 3V. 4.4 406 53G 5BI 5RE 6PF 70F 7RV 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWTL AAYZH AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACUHS ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DXH E3Z EAD EAP EAS EBC EBD EBLON EBS EE. EHN EIOEI EJD EMB EMK EMOBN ENB ENC ENX EPL EPT ESX EX3 F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA HCIFZ HMCUK HZ~ IWAJR JSO KQ8 LGEZI LOTEE M1P M7P NADUK NAO NAPCQ NQJWS NXXTH O9- OK1 P2P PCD PQQKQ PROAC PSQYO Q2X Q~Q RNS RNT RNTTT ROL SNX SNYQT SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UKHRP W2D WH7 WOW ZGI ZXP ~8M AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION JZLTJ PHGZM PHGZT 7QL 7T7 7TK 7U9 7XB 8FD 8FE 8FH 8FK ABRTQ AZQEC C1K DWQXO FR3 GNUQQ H94 K9. LK8 M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c452t-21fdea18c3f162b9dffc7be182a6dd6d5788aa31a58ee3edecbba1ddcfbf5da3 |
IEDL.DBID | 7X7 |
ISSN | 1362-4393 1476-5624 |
IngestDate | Thu Aug 21 18:34:51 EDT 2025 Tue Aug 05 11:10:33 EDT 2025 Sat Aug 23 13:31:33 EDT 2025 Thu Apr 24 22:50:22 EDT 2025 Tue Jul 01 01:16:16 EDT 2025 Fri Feb 21 02:38:01 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Language | English |
License | Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c452t-21fdea18c3f162b9dffc7be182a6dd6d5788aa31a58ee3edecbba1ddcfbf5da3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Authors’ Contributions: CSF was responsible for study design, analyzing the data, interpreting the data, and wrote the first draft of the manuscript. OKL was responsible for running the assays, interpreting the data, and provided critical feedback on the manuscript. AR and IL consented the participants, collected the urine samples, collected symptom data, and provided critical feedback on the manuscript. BS performed the first step of urine processing, collected the symptom data, provided data management, and provided critical feedback on the manuscript. SG was responsible for study design, data interpretation, and provided critical feedback on the manuscript. |
ORCID | 0000-0002-6233-1070 0000-0003-1213-1959 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC11702270 |
PMID | 32963362 |
PQID | 2565277372 |
PQPubID | 38130 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11702270 proquest_miscellaneous_2445426624 proquest_journals_2565277372 crossref_primary_10_1038_s41393_020_00552_x crossref_citationtrail_10_1038_s41393_020_00552_x springer_journals_10_1038_s41393_020_00552_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-09-01 |
PublicationDateYYYYMMDD | 2021-09-01 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Spinal cord |
PublicationTitleAbbrev | Spinal Cord |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Gupta, Preece, Haynes, Becknell, Ching (CR16) 2019; 25 Nickolas, Forster, Sise, Barasch, Valle, Viltard (CR12) 2012; 82 Rabadi, Mayanna, Vincent (CR21) 2013; 51 Tractenberg, Groah, Rounds, Ljungberg, Schladen (CR9) 2018; 13 Fouts, Pieper, Szpakowski, Pohl, Knoblach, Suh (CR6) 2012; 10 Lee, Kim, Kang, Park (CR14) 2015; 30 Gribble, Puterman, McCallum (CR4) 1989; 70 CR13 Harris, Taylor, Thielke, Payne, Gonzalez, Conde (CR19) 2009; 42 Yilmaz, Sevketoglu, Gedikbasi, Karyagar, Kiyak, Mulazimoglu (CR26) 2009; 24 Nickolas, O’Rourke, Yang, Sise, Canetta, Barasch (CR10) 2008; 148 Schmidt-Ott, Mori, Li, Kalandadze, Cohen, Devarajan (CR25) 2007; 18 Cardenas, Hooton (CR1) 1995; 76 Krzeminska, Wyczalkowska-Tomasik, Korytowska, Paczek (CR23) 2016; 30 Wolfe, Toh, Shibata, Rong, Kenton, FitzGerald (CR7) 2012; 50 Paragas, Kulkarni, Werth, Schmidt-Ott, Forster, Deng (CR24) 2014; 124 Adriaansen, Post, de Groot, van Asbeck, Stolwijk-Swüste, Tepper (CR2) 2013; 45 Forster, Jackson, Ma, Bennett, Shah, Goldstein (CR17) 2018; 33 Makris, Stefani, Makri, Panagou, Lagiou, Sarli (CR11) 2015; 48 Trautner, Petersen, Hysong, Horwitz, Kelly, Naik (CR22) 2014; 42 Chaudhry, Madden-Fuentes, Ortiz, Balsara, Tang, Nseyo (CR18) 2014; 191 Hooton, Bradley, Cardenas, Colgan, Geerlings, Rice (CR3) 2010; 50 Groah, Pérez-Losada, Caldovic, Ljungberg, Sprague, Castro-Nallar (CR5) 2016; 196 Skelton, Grigoryan, Holmes, Poon, Trautner (CR8) 2018; 99 Tractenberg, Garver, Ljungberg, Schladen, Groah (CR20) 2017; 12 Forster, Goldstein, Pohl, Jackson (CR27) 2019; 15 Hatipoglu, Sevketoglu, Gedikbasi, Yilmaz, Kiyak, Mulazimoglu (CR15) 2011; 26 DD Cardenas (552_CR1) 1995; 76 SL Groah (552_CR5) 2016; 196 A Yilmaz (552_CR26) 2009; 24 MJ Gribble (552_CR4) 1989; 70 MH Rabadi (552_CR21) 2013; 51 S Hatipoglu (552_CR15) 2011; 26 CS Forster (552_CR27) 2019; 15 F Skelton (552_CR8) 2018; 99 KM Schmidt-Ott (552_CR25) 2007; 18 E Krzeminska (552_CR23) 2016; 30 RE Tractenberg (552_CR9) 2018; 13 BW Trautner (552_CR22) 2014; 42 TM Hooton (552_CR3) 2010; 50 TL Nickolas (552_CR12) 2012; 82 AJ Wolfe (552_CR7) 2012; 50 RE Tractenberg (552_CR20) 2017; 12 N Paragas (552_CR24) 2014; 124 R Chaudhry (552_CR18) 2014; 191 CS Forster (552_CR17) 2018; 33 552_CR13 HE Lee (552_CR14) 2015; 30 TL Nickolas (552_CR10) 2008; 148 DE Fouts (552_CR6) 2012; 10 S Gupta (552_CR16) 2019; 25 JJE Adriaansen (552_CR2) 2013; 45 PA Harris (552_CR19) 2009; 42 K Makris (552_CR11) 2015; 48 |
References_xml | – volume: 48 start-page: 1291 year: 2015 end-page: 7 ident: CR11 article-title: Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: analytical performance and establishment of reference values publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2015.08.003 – volume: 30 start-page: 956 year: 2016 end-page: 60 ident: CR23 article-title: Comparison of two methods for determination of NGAL levels in urine: ELISA and CMIA publication-title: J Clin Lab Anal doi: 10.1002/jcla.21962 – volume: 82 start-page: 718 year: 2012 end-page: 22. ident: CR12 article-title: NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease publication-title: Kidney Int doi: 10.1038/ki.2012.195 – volume: 24 start-page: 2387 year: 2009 end-page: 92 ident: CR26 article-title: Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin publication-title: Pediatr Nephrol doi: 10.1007/s00467-009-1279-6 – volume: 10 year: 2012 ident: CR6 article-title: Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury publication-title: J Transl Med doi: 10.1186/1479-5876-10-174 – volume: 42 start-page: 377 year: 2009 end-page: 81. ident: CR19 article-title: Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support publication-title: J Biomed Inf doi: 10.1016/j.jbi.2008.08.010 – volume: 18 start-page: 407 year: 2007 end-page: 13. ident: CR25 article-title: Dual action of neutrophil gelatinase-associated lipocalin publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006080882 – volume: 196 start-page: 579 year: 2016 end-page: 87 ident: CR5 article-title: Redefining healthy urine: a cross-sectional exploratory metagenomic study of people with and without bladder dysfunction publication-title: J Urol doi: 10.1016/j.juro.2016.01.088 – volume: 26 start-page: 1263 year: 2011 end-page: 8 ident: CR15 article-title: Urinary MMP-9/NGAL complex in children with acute cystitis publication-title: Pediatr Nephrol doi: 10.1007/s00467-011-1856-3 – volume: 42 start-page: 653 year: 2014 end-page: 8 ident: CR22 article-title: Overtreatment of asymptomatic bacteriuria: Identifying provider barriers to evidence-based care publication-title: Am J Infect Control doi: 10.1016/j.ajic.2014.02.003 – volume: 99 start-page: 219 year: 2018 end-page: 25 ident: CR8 article-title: Routine urine testing at the spinal cord injury annual evaluation leads to unnecessary antibiotic use: a pilot study and future directions publication-title: Arch Phys Med Rehabil doi: 10.1016/j.apmr.2017.10.005 – volume: 15 start-page: 155.e1 year: 2019 end-page: 6 ident: CR27 article-title: Association between urodynamic parameters and urine neutrophil gelatinase–associated lipocalin concentrations in children with neuropathic bladders publication-title: J Pediatr Urol doi: 10.1016/j.jpurol.2018.12.008 – volume: 148 start-page: 810 year: 2008 end-page: 9 ident: CR10 article-title: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury publication-title: Ann Intern Med doi: 10.7326/0003-4819-148-11-200806030-00003 – volume: 50 start-page: 1376 year: 2012 end-page: 83 ident: CR7 article-title: Evidence of uncultivated bacteria in the adult female bladder publication-title: J Clin Microbiol doi: 10.1128/JCM.05852-11 – volume: 30 start-page: 123 year: 2015 end-page: 30 ident: CR14 article-title: The diagnosis of febrile urinary tract infection in children may be facilitated by urinary biomarkers publication-title: Pediatr Nephrol doi: 10.1007/s00467-014-2905-5 – volume: 45 start-page: 1016 year: 2013 end-page: 22 ident: CR2 article-title: Secondary health conditions in persons with spinal cord injury: a longitudinal study from one to five years post-discharge publication-title: J Rehabil Med doi: 10.2340/16501977-1207 – volume: 33 start-page: 1365 year: 2018 end-page: 74 ident: CR17 article-title: Predictive ability of NGAL in identifying urinary tract infection in children with neurogenic bladders publication-title: Pediatr Nephrol doi: 10.1007/s00467-018-3936-0 – ident: CR13 – volume: 12 start-page: e0171114 year: 2017 ident: CR20 article-title: Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes publication-title: PLoS ONE doi: 10.1371/journal.pone.0171114 – volume: 124 start-page: 2963 year: 2014 end-page: 76 ident: CR24 article-title: α-Intercalated cells defend the urinary system from bacterial infection publication-title: J Clin Invest doi: 10.1172/JCI71630 – volume: 191 start-page: 1454 year: 2014 end-page: 61. ident: CR18 article-title: Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host publication-title: J Urol doi: 10.1016/j.juro.2013.12.013 – volume: 25 start-page: 214 year: 2019 end-page: 21 ident: CR16 article-title: Differentiating asymptomatic bacteriuria from urinary tract infection in the pediatric neurogenic bladder population: NGAL as a promising biomarker publication-title: Top Spinal Cord Inj Rehabil doi: 10.1310/sci2503-214 – volume: 76 start-page: 272 year: 1995 end-page: 80 ident: CR1 article-title: Urinary tract infection in persons with spinal cord injury publication-title: Arch Phys Med Rehabil doi: 10.1016/S0003-9993(95)80615-6 – volume: 51 start-page: 784 year: 2013 end-page: 8 ident: CR21 article-title: Predictors of mortality in veterans with traumatic spinal cord injury publication-title: Spinal Cord doi: 10.1038/sc.2013.77 – volume: 50 start-page: 625 year: 2010 end-page: 63. ident: CR3 article-title: Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America publication-title: Clin Infect Dis doi: 10.1086/650482 – volume: 70 start-page: 376 year: 1989 end-page: 9 ident: CR4 article-title: Pyuria: its relationship to bacteriuria in spinal cord injured patients on intermittent catheterization publication-title: Arch Phys Med Rehabil – volume: 13 start-page: e0197568 year: 2018 ident: CR9 article-title: Preliminary validation of a Urinary Symptom Questionnaire for individuals with Neuropathic Bladder using Intermittent Catheterization (USQNB-IC): a patient-centered patient reported outcome publication-title: PLoS ONE doi: 10.1371/journal.pone.0197568 – volume: 196 start-page: 579 year: 2016 ident: 552_CR5 publication-title: J Urol doi: 10.1016/j.juro.2016.01.088 – volume: 148 start-page: 810 year: 2008 ident: 552_CR10 publication-title: Ann Intern Med doi: 10.7326/0003-4819-148-11-200806030-00003 – volume: 48 start-page: 1291 year: 2015 ident: 552_CR11 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2015.08.003 – volume: 82 start-page: 718 year: 2012 ident: 552_CR12 publication-title: Kidney Int doi: 10.1038/ki.2012.195 – volume: 42 start-page: 653 year: 2014 ident: 552_CR22 publication-title: Am J Infect Control doi: 10.1016/j.ajic.2014.02.003 – volume: 191 start-page: 1454 year: 2014 ident: 552_CR18 publication-title: J Urol doi: 10.1016/j.juro.2013.12.013 – volume: 12 start-page: e0171114 year: 2017 ident: 552_CR20 publication-title: PLoS ONE doi: 10.1371/journal.pone.0171114 – volume: 50 start-page: 625 year: 2010 ident: 552_CR3 publication-title: Clin Infect Dis doi: 10.1086/650482 – volume: 50 start-page: 1376 year: 2012 ident: 552_CR7 publication-title: J Clin Microbiol doi: 10.1128/JCM.05852-11 – volume: 70 start-page: 376 year: 1989 ident: 552_CR4 publication-title: Arch Phys Med Rehabil – volume: 25 start-page: 214 year: 2019 ident: 552_CR16 publication-title: Top Spinal Cord Inj Rehabil doi: 10.1310/sci2503-214 – volume: 42 start-page: 377 year: 2009 ident: 552_CR19 publication-title: J Biomed Inf doi: 10.1016/j.jbi.2008.08.010 – volume: 26 start-page: 1263 year: 2011 ident: 552_CR15 publication-title: Pediatr Nephrol doi: 10.1007/s00467-011-1856-3 – volume: 24 start-page: 2387 year: 2009 ident: 552_CR26 publication-title: Pediatr Nephrol doi: 10.1007/s00467-009-1279-6 – volume: 30 start-page: 123 year: 2015 ident: 552_CR14 publication-title: Pediatr Nephrol doi: 10.1007/s00467-014-2905-5 – volume: 51 start-page: 784 year: 2013 ident: 552_CR21 publication-title: Spinal Cord doi: 10.1038/sc.2013.77 – volume: 45 start-page: 1016 year: 2013 ident: 552_CR2 publication-title: J Rehabil Med doi: 10.2340/16501977-1207 – volume: 124 start-page: 2963 year: 2014 ident: 552_CR24 publication-title: J Clin Invest doi: 10.1172/JCI71630 – volume: 18 start-page: 407 year: 2007 ident: 552_CR25 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006080882 – volume: 99 start-page: 219 year: 2018 ident: 552_CR8 publication-title: Arch Phys Med Rehabil doi: 10.1016/j.apmr.2017.10.005 – ident: 552_CR13 doi: 10.1681/ASN.2009010065 – volume: 10 year: 2012 ident: 552_CR6 publication-title: J Transl Med doi: 10.1186/1479-5876-10-174 – volume: 13 start-page: e0197568 year: 2018 ident: 552_CR9 publication-title: PLoS ONE doi: 10.1371/journal.pone.0197568 – volume: 33 start-page: 1365 year: 2018 ident: 552_CR17 publication-title: Pediatr Nephrol doi: 10.1007/s00467-018-3936-0 – volume: 15 start-page: 155.e1 year: 2019 ident: 552_CR27 publication-title: J Pediatr Urol doi: 10.1016/j.jpurol.2018.12.008 – volume: 30 start-page: 956 year: 2016 ident: 552_CR23 publication-title: J Clin Lab Anal doi: 10.1002/jcla.21962 – volume: 76 start-page: 272 year: 1995 ident: 552_CR1 publication-title: Arch Phys Med Rehabil doi: 10.1016/S0003-9993(95)80615-6 |
SSID | ssj0009198 |
Score | 2.350796 |
Snippet | Study design
Secondary analysis of urine samples collected from a prospective within-subject clinical trial.
Objectives
Describe the baseline variation in... Study designSecondary analysis of urine samples collected from a prospective within-subject clinical trial.ObjectivesDescribe the baseline variation in urine... Secondary analysis of urine samples collected from a prospective within-subject clinical trial.STUDY DESIGNSecondary analysis of urine samples collected from a... |
SourceID | pubmedcentral proquest crossref springer |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 959 |
SubjectTerms | 692/53/2421 692/699/2768/1865 Adults Anatomy Biomedical and Life Sciences Biomedicine Clinical trials Gelatinase Human Physiology Leukocytes (neutrophilic) Lipocalin Neurochemistry Neuropsychology Neurosciences Neutrophils Secondary analysis Urinary tract Urine Urogenital system |
Title | The association between urine neutrophil gelatinase-associated lipocalin and UTI in people with neurogenic lower urinary tract dysfunction |
URI | https://link.springer.com/article/10.1038/s41393-020-00552-x https://www.proquest.com/docview/2565277372 https://www.proquest.com/docview/2445426624 https://pubmed.ncbi.nlm.nih.gov/PMC11702270 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aBEovpU_qNg0q9NaKWPJLPpW2JKSFhlI2sDejlxvDot3seiH5C_3V1cjymg00N4Nky2gkzWjmm_kAPkh_oa5TLmlVp4rmTFgqtGJUyEpIJZS_dYVqnxfl-WX-Y17Mo8NtE2GV45kYDmqz1OgjP_GqueAVkqp8Xl1TZI3C6Gqk0HgIh1i6DCFd1byaiu6ywIXLhsygOotJM2kmTjb-8EbkGse86qLg9GZfMU3W5l2s5J2AadBDZ0_hSTQgyZdB4s_ggXXP4dHPGCJ_AX-94ImcJp1EJBZBt7olzm779XJ11S3In4CDc16N0bG_NWTRrVC9dY5IZ8jl7DvxjwPOnKDTloQKmH7ZdZoskGItfFiub0mPCVfE3G5QV-LQL2F2djr7dk4j4QLVecF7yllrrGRCZy0ruapN2-pKWX8FkSUyT_ndLaTMmCyEtZk1VislmTG6VW1hZPYKDtzS2ddAvDHcmtpmZanKXAnfblpuuFBlldpa8ATYONmNjsXIkRNj0YSgeCaaQUCNF1ATBNTcJPBx985qKMVxb--jUYZN3JabZlpECbzfNfsNhVES6exy6_vkeYFmC88TEHuy342KJbn3W1x3FUpzI48P51WawKdxmUyj__9n39z_s2_hMUcoTYC2HcFBv97ad94W6tVxWPDHcPj19OLX73-llw4N |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IK4ibICR4Amsxc7NeUCIy6aWbRVCnbS3yI4dFqlKuzYV61_gv_Af8XGSRp3E3vYWyY4d5Tv2Ofa5fABvpT1Qpz6XNEl9RUMmDBW5YlTIREgllD11uWqf43h4Fn4_j8534G-XC4Nhld2e6DZqPcvxjvzAquaIJ0iq8ml-SZE1Cr2rHYVGIxbHZv3bHtmWH0ffLL7vOD86nHwd0pZVgOZhxGvKWaGNZCIPChZzleqiyBNlrJ0tY6RXsiIspAyYjIQxgdEmV0oyrfNCFZGWgR32DuyGgT3JDGD3y-H4x8--yi9z5LusSUVKgzZLxw_EwdJqCwyV45jIHUWcXm1rwt68vR6cec1D6xTf0UN40Fqs5HMjYo9gx1SP4e5p65N_An-spBHZo0za0C-C9_iGVGZVL2bzi3JKfrnAu8rqTdr1N5pMyznq07IistLkbDIi9rEJbCd4S0xcyU0r52VOpsjp5gaWizWpMcOL6PUSlTNO_RQmt4HFMxhUs8o8B2Kt70KnJohjFYdK2HZdcM2FihPfpIJ7wLqfneVt9XMk4ZhmzgsfiKwBKLMAZQ6g7MqD95t35k3tjxt773cYZu0-sMx6qfXgzabZrmB0y8jKzFa2TxhGaCfx0AOxhf1mVqwBvt1SlReuFjgSB3Ge-B586MSkn_3_H_vi5o99DfeGk9OT7GQ0Pt6D-xzjeFxc3T4M6sXKvLSGWK1eteJPILvlBfcPCh9O2g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELfGkCZeEH9F2AAjwRNYrZ1_zgNCiFGtDCYeOqlvlh07W6Qq7dpUrF-Bb8S3485JGnUSe9tbJDt2lDv7zr7f3Y-QdxoO1NlQaJZmQ8MiLh2TueFM6lRqIw2cuny1z7Pk5Dz6Po2ne-RvlwuDsMpuT_QbtZ3neEc-ANMcixRJVQZFC4v4dTz6vLhiyCCFkdaOTqNRkVO3-Q3Ht9Wn8THI-r0Qo2-TryesZRhgeRSLmgleWKe5zMOCJ8Jktijy1DjwuXWCVEugzlLrkOtYOhc663JjNLc2L0wRWx3CsPfI_TSMOS6xdJr29X65p-HlTVJSFrb5OsNQDlZgNxA0JzClO44Fu961ib2jexOmeSNW603g6BF52Pqu9EujbI_JnquekIOfbXT-KfkDOkd1L2_agsAo3ug7Wrl1vZwvLssZvfAQvAosKOv6O0tn5QIta1lRXVl6PhlTeGwg7hTvi6kvvgkaX-Z0huxufmC93NAac72o3azQTOPUz8jkLiTxnOxX88q9IBT88MJmLkwSk0RGQrsthBXSJOnQZVIEhHc_W-VtHXSk45gpH48PpWoEpEBAygtIXQfkw_adRVMF5NbeR50MVbsjrFSvvwF5u22GtYwBGl25-Rr6RFGMHpOIAiJ3ZL-dFauB77ZU5aWvCo4UQkKkw4B87NSkn_3_H_vy9o99Qw5gmakf47PTQ_JAIKDHA-yOyH69XLtX4JHV5rXXfUrUHa-1f3oDUao |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+urine+neutrophil+gelatinase-associated+lipocalin+and+UTI+in+people+with+neurogenic+lower+urinary+tract+dysfunction&rft.jtitle=Spinal+cord&rft.au=ster%2C+Catherine+S&rft.au=Lamanna%2C+Olivia+K&rft.au=Rounds%2C+Amanda&rft.au=Sprague%2C+Bruce+M&rft.date=2021-09-01&rft.pub=Nature+Publishing+Group&rft.issn=1362-4393&rft.eissn=1476-5624&rft.volume=59&rft.issue=9&rft.spage=959&rft.epage=966&rft_id=info:doi/10.1038%2Fs41393-020-00552-x&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1362-4393&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1362-4393&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1362-4393&client=summon |